{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:09:27Z","timestamp":1789002567105,"version":"build-2803163510"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":1933,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"publisher","award":["MIUR 10484\/R"],"award-info":[{"award-number":["MIUR 10484\/R"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Thymosin alpha 1 (T\u03b11) is a powerful modulator of immunity and inflammation. Despite years of studies, there are a few reports evaluating serum T\u03b11 in health and disease. We studied a cohort of healthy individuals in comparison with patients affected by chronic inflammatory autoimmune diseases. Sera from 120 blood donors (healthy controls, HC), 120 patients with psoriatic arthritis (PsA), 40 with rheumatoid arthritis (RA) and 40 with systemic lupus erythematosus (SLE), attending the Transfusion Medicine or the Rheumatology Clinic at the Policlinico Tor Vergata, Rome, Italy, were tested for T\u03b11 content by means of a commercial enzyme-linked immunosorbent assay (ELISA) kit. Data were analysed in relation to demographic and clinical characteristics of patients and controls. A gender difference was found in the HC group, where females had lower serum T\u03b11 levels than males (P\u2009&amp;lt;\u20090\u00b70001). Patients had lower serum T\u03b11 levels than HC (P\u2009&amp;lt;\u20090\u00b70001), the lowest were observed in PsA group (P\u2009&amp;lt;\u20090\u00b70001 versus all the other groups). Among all patients, those who at the time of blood collection were taking disease-modifying anti-rheumatic drugs (DMARD) plus steroids had significantly higher T\u03b11 levels than those taking DMARD alone (P\u2009=\u20090\u00b7044) or no treatment (P\u2009&amp;lt;\u20090\u00b70001), but not of those taking steroids alone (P\u2009=\u20090\u00b7280). However, whichever type of treatment was taken by the patients, serum T\u03b11 was still significantly lower than in HC and there was no treatment-related difference in PsA group. Further prospective studies are necessary to confirm and deepen these observations. They might improve our understanding on the regulatory role of T\u03b11 in health and disease and increase our knowledge of the pathogenesis of chronic inflammatory autoimmune diseases.<\/jats:p>","DOI":"10.1111\/cei.12833","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T08:28:55Z","timestamp":1467102535000},"page":"39-45","source":"Crossref","is-referenced-by-count":22,"title":["Serum thymosin \u03b1 1 levels in patients with chronic inflammatory autoimmune diseases"],"prefix":"10.1093","volume":"186","author":[{"given":"F","family":"Pica","sequence":"first","affiliation":[{"name":"Departments of Experimental Medicine and Surgery, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Chimenti","sequence":"additional","affiliation":[{"name":"Medicine of Systems, Rheumatology, Allergology and Clinical Immunology, University Tor Vergata, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Gaziano","sequence":"additional","affiliation":[{"name":"Departments of Experimental Medicine and Surgery, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bu\u00e8","sequence":"additional","affiliation":[{"name":"Departments of Experimental Medicine and Surgery, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I A","family":"Casalinuovo","sequence":"additional","affiliation":[{"name":"Departments of Experimental Medicine and Surgery, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Triggianese","sequence":"additional","affiliation":[{"name":"Medicine of Systems, Rheumatology, Allergology and Clinical Immunology, University Tor Vergata, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Conigliaro","sequence":"additional","affiliation":[{"name":"Medicine of Systems, Rheumatology, Allergology and Clinical Immunology, University Tor Vergata, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Di Carlo","sequence":"additional","affiliation":[{"name":"Departments of Experimental Medicine and Surgery, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Cordero","sequence":"additional","affiliation":[{"name":"SIMT Policlinico Tor Vergata, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Adorno","sequence":"additional","affiliation":[{"name":"SIMT Policlinico Tor Vergata, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Volpi","sequence":"additional","affiliation":[{"name":"Translational Medicine, University Tor Vergata, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Perricone","sequence":"additional","affiliation":[{"name":"Medicine of Systems, Rheumatology, Allergology and Clinical Immunology, University Tor Vergata, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Garaci","sequence":"additional","affiliation":[{"name":"Departments of Experimental Medicine and Surgery, Italy"},{"name":"IRCCS San Raffaele Pisana, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,8,1]]},"reference":[{"key":"2021120807490150000_cei12833-bib-0001","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1073\/pnas.69.7.1800","article-title":"Purification and biological activity of thymosin, a hormone of the thymus gland","volume":"69","author":"Goldstein","year":"1972","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021120807490150000_cei12833-bib-0002","doi-asserted-by":"crossref","first-page":"13286","DOI":"10.1074\/jbc.M213005200","article-title":"Prothymosin alpha is processed to thymosin alpha 1 and thymosin alpha 11 by a lysosomal asparaginyl endopeptidase","volume":"278","author":"Sarandeses","year":"2003","journal-title":"J Biol Chem"},{"key":"2021120807490150000_cei12833-bib-0003","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0167-4838(92)90422-A","article-title":"Thymosin alpha 1 is a native peptide in several tissues","volume":"1120","author":"Franco","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"2021120807490150000_cei12833-bib-0004","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1196\/annals.1415.044","article-title":"Thymosin alpha 1: from bench to bedside","volume":"1112","author":"Garaci","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"2021120807490150000_cei12833-bib-0005","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1196\/annals.1415.002","article-title":"Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance","volume":"1112","author":"Romani","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"2021120807490150000_cei12833-bib-0006","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF01771450","article-title":"Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice","volume":"32","author":"Garaci","year":"1990","journal-title":"Cancer Immunol Immunother"},{"key":"2021120807490150000_cei12833-bib-0007","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1517\/14712590902911412","article-title":"From lab to bedside: emerging clinical applications of thymosin alpha 1","volume":"9","author":"Goldstein","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"2021120807490150000_cei12833-bib-0008","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1517\/14712598.2015.1009034","article-title":"Thymosin \u03b11 inserts N terminus into model membranes assuming a helical conformation","volume":"15","author":"Nepravishta","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"2021120807490150000_cei12833-bib-0009","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","article-title":"Rheumatoid arthritis","volume":"358","author":"Lee","year":"2001","journal-title":"Lancet"},{"key":"2021120807490150000_cei12833-bib-0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.autrev.2012.10.002","article-title":"Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways","volume":"12","author":"Chimenti","year":"2013","journal-title":"Autoimmun Rev"},{"key":"2021120807490150000_cei12833-bib-0011","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3389\/fimmu.2015.00610","article-title":"Disturbed T cell signaling and altered Th17 and regulatory T cell subsets in the pathogenesis of systemic lupus erythematosus","volume":"6","author":"Rother","year":"2015","journal-title":"Front Immunol"},{"key":"2021120807490150000_cei12833-bib-0012","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1017\/S2040174411000353","article-title":"Epigenetic alterations and autoimmune disease","volume":"2","author":"Renaudineau","year":"2011","journal-title":"J Dev Orig Health Dis"},{"key":"2021120807490150000_cei12833-bib-0013","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1038\/ncomms7046","article-title":"Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis","volume":"6","author":"Bowes","year":"2015","journal-title":"Nat Commun"},{"key":"2021120807490150000_cei12833-bib-0014","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/cei.12335","article-title":"Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during Etanercept treatment","volume":"177","author":"Conigliaro","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2021120807490150000_cei12833-bib-0015","doi-asserted-by":"crossref","first-page":"e1887","DOI":"10.1038\/cddis.2015.246","article-title":"The interplay between inflammation and metabolism in rheumatoid arthritis","volume":"6","author":"Chimenti","year":"2015","journal-title":"Cell Death Dis"},{"key":"2021120807490150000_cei12833-bib-0016","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021120807490150000_cei12833-bib-0017","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2021120807490150000_cei12833-bib-0018","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2021120807490150000_cei12833-bib-0019","first-page":"579","article-title":"Development of a disease activity score based on judgment in clinical practice by rheumatologists","volume":"20","author":"Van der Heijde","year":"1993","journal-title":"J Rheumatol"},{"key":"2021120807490150000_cei12833-bib-0020","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2021120807490150000_cei12833-bib-0021","article-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2016"},{"key":"2021120807490150000_cei12833-bib-0022","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/sim.4780090710","article-title":"More powerful procedures for multiple significance testing","volume":"9","author":"Hochberg","year":"1990","journal-title":"Stat Med"},{"key":"2021120807490150000_cei12833-bib-0023","doi-asserted-by":"crossref","first-page":"J109","DOI":"10.1016\/j.jaut.2011.10.003","article-title":"Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity","volume":"38","author":"Quintero","year":"2012","journal-title":"J Autoimmun"},{"key":"2021120807490150000_cei12833-bib-0024","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood-2006-02-004762","article-title":"Thymosin a1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance","volume":"108","author":"Romani","year":"2006","journal-title":"Blood"},{"key":"2021120807490150000_cei12833-bib-0025","first-page":"287","article-title":"Thymosin administration in autoimmune disorders","volume":"2","author":"Lavastida","year":"1981","journal-title":"Thymus"},{"key":"2021120807490150000_cei12833-bib-0026","doi-asserted-by":"crossref","first-page":"e39853","DOI":"10.1371\/journal.pone.0039853","article-title":"Sex differences in the response to viral infections: TLR8 and TLR9 ligand stimulation induce higher IL 10 production in males","volume":"7","author":"Torcia","year":"2012","journal-title":"PLOS ONE"},{"key":"2021120807490150000_cei12833-bib-0027","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2815","article-title":"The X chromosome in immune functions: when a chromosome makes the difference","volume":"10","author":"Libert","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"2021120807490150000_cei12833-bib-0028","doi-asserted-by":"crossref","first-page":"e000025","DOI":"10.1136\/rmdopen-2014-000025","article-title":"What makes psoriatic and rheumatoid arthritis so different?","volume":"1","author":"Veale","year":"2015","journal-title":"RMD Open"},{"key":"2021120807490150000_cei12833-bib-0029","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4049\/jimmunol.128.1.368","article-title":"Immunochemical studies on thymosin: radioimmunoassay of thymosin alpha 1","volume":"128","author":"McClure","year":"1982","journal-title":"J Immunol"},{"key":"2021120807490150000_cei12833-bib-0030","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1021\/acs.biochem.5b01345","article-title":"Thymosin \u03b11 interacts with exposed phosphatidylserine in membrane models and in cells and uses serum albumin as carrier","volume":"55","author":"Mandaliti","year":"2016","journal-title":"Biochemistry"},{"key":"2021120807490150000_cei12833-bib-0031","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/vim.1991.4.195","article-title":"Low thymosin alpha-1 concentrations in patients chronically infected with the hepatitis B virus","volume":"4","author":"Sherman","year":"1991","journal-title":"Viral Immunol"},{"key":"2021120807490150000_cei12833-bib-0032","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0165-5728(99)00237-4","article-title":"Melatonin is responsible for the nocturnal increase observed in serum and thymus of thymosin alpha1 and thymulin concentrations: observations in rats and humans","volume":"103","author":"Molinero","year":"2000","journal-title":"J Neuroimmunol"},{"key":"2021120807490150000_cei12833-bib-0033","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.urolonc.2012.03.011","article-title":"Plasma thymosin-\u03b11 level as a potential biomarker in urothelial and renal cell carcinoma","volume":"31","author":"Jou","year":"2013","journal-title":"Urol Oncol"},{"key":"2021120807490150000_cei12833-bib-0034","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1749-6632.2012.06707.x","article-title":"Thymosin \u03b11 as a stimulatory agent of innate cell-mediated immune response","volume":"1270","author":"Serafino","year":"2012","journal-title":"Ann NY Acad Sci"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12833","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12833","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/186\/1\/39\/41642339\/cei12833.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/186\/1\/39\/41642339\/cei12833.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T23:26:45Z","timestamp":1718666805000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/186\/1\/39\/6412061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,8,1]]},"published-print":{"date-parts":[[2016,9,4]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12833","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,10]]},"published":{"date-parts":[[2016,8,1]]}}}